DiA and Edan Instruments Collaborate to Offer AI-Based Cardiac Ultrasound Solutions
|
By MedImaging International staff writers Posted on 10 Sep 2019 |
|
Image: DiA Imaging Analysis has partnered with Edan Instruments to offer DiA\'s AI-based cardiac analysis solutions as an integrated part of Edan\'s ultrasound devices (Photo courtesy of DiA Imaging Analysis).
DiA Imaging Analysis Ltd. {(DiA) Be'er Sheva, Israel}, a provider of artificial intelligence (AI)-powered ultrasound analysis solutions, has entered into a partnership with Edan Instruments Inc. (Shenzen, China), a medical products and services company, to offer DiA's AI-based cardiac analysis solutions as an integrated part of Edan's ultrasound devices.
DiA uses advanced AI-based technology to assist clinicians at all levels of experience to acquire and analyze ultrasound images – objectively and accurately, improving patient management. DiA's solutions are cross-platform that can be easily implemented to ultrasound devices and healthcare IT systems, as an integrated part of clinician's workflow. DiA's AI-based cardiac solution, LVivo Toolbox, provides a fast and objective cardiac ultrasound analysis that assists in reducing the subjectivity and increasing the efficiency of clinician's decision-making process. LVivo Toolbox can be easily used by clinicians with various levels of experience and fits to operate as an integrated add-on solution on ultrasound devices and Healthcare IT systems.
Edan is a healthcare company engaged in the research, development, manufacture, sales of medical electronic equipment products and in-vitro diagnostic products, as well as the provision of related services. Edan has developed unique ultrasound devices that offer advanced imaging technologies, dual touch screens and a gesture-control user interface, supporting a wide range of clinical applications and delivering excellent image clarity.
"Edan provides innovative and high-quality medical products and services, bringing the most ground-breaking imaging technologies to its customers that best fit their clinical setting and needs," said Renfu Zhang, Edan's ultrasound product line director. "With DiA's AI-based cardiac solution, we will offer our customers an additional layer of automated AI-based analysis, as part of their everyday workflow."
"We are thrilled to partner with Edan Instruments and join forces to offer Edan's customers objective and fast clinical indications that they often struggle to find visually," said Hila Goldman Aslan, DiA's CEO and co-founder.
Related Links:
DiA Imaging Analysis
Edan Instruments
DiA uses advanced AI-based technology to assist clinicians at all levels of experience to acquire and analyze ultrasound images – objectively and accurately, improving patient management. DiA's solutions are cross-platform that can be easily implemented to ultrasound devices and healthcare IT systems, as an integrated part of clinician's workflow. DiA's AI-based cardiac solution, LVivo Toolbox, provides a fast and objective cardiac ultrasound analysis that assists in reducing the subjectivity and increasing the efficiency of clinician's decision-making process. LVivo Toolbox can be easily used by clinicians with various levels of experience and fits to operate as an integrated add-on solution on ultrasound devices and Healthcare IT systems.
Edan is a healthcare company engaged in the research, development, manufacture, sales of medical electronic equipment products and in-vitro diagnostic products, as well as the provision of related services. Edan has developed unique ultrasound devices that offer advanced imaging technologies, dual touch screens and a gesture-control user interface, supporting a wide range of clinical applications and delivering excellent image clarity.
"Edan provides innovative and high-quality medical products and services, bringing the most ground-breaking imaging technologies to its customers that best fit their clinical setting and needs," said Renfu Zhang, Edan's ultrasound product line director. "With DiA's AI-based cardiac solution, we will offer our customers an additional layer of automated AI-based analysis, as part of their everyday workflow."
"We are thrilled to partner with Edan Instruments and join forces to offer Edan's customers objective and fast clinical indications that they often struggle to find visually," said Hila Goldman Aslan, DiA's CEO and co-founder.
Related Links:
DiA Imaging Analysis
Edan Instruments
X-ray Diagnostic System
FDX Visionary-A
Mammo DR Retrofit Solution
DR Retrofit Mammography
Digital Intelligent Ferromagnetic Detector
Digital Ferromagnetic Detector
Biopsy Software
Affirm® Contrast
Latest Industry News News
- Nuclear Medicine Set for Continued Growth Driven by Demand for Precision Diagnostics
- GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
- Patient-Specific 3D-Printed Phantoms Transform CT Imaging
- Siemens and Sectra Collaborate on Enhancing Radiology Workflows
- Bracco Diagnostics and ColoWatch Partner to Expand Availability CRC Screening Tests Using Virtual Colonoscopy
- Mindray Partners with TeleRay to Streamline Ultrasound Delivery
- Philips and Medtronic Partner on Stroke Care
- Siemens and Medtronic Enter into Global Partnership for Advancing Spine Care Imaging Technologies
- RSNA 2024 Technical Exhibits to Showcase Latest Advances in Radiology
- Bracco Collaborates with Arrayus on Microbubble-Assisted Focused Ultrasound Therapy for Pancreatic Cancer
- Innovative Collaboration to Enhance Ischemic Stroke Detection and Elevate Standards in Diagnostic Imaging
- RSNA 2024 Registration Opens
- Microsoft collaborates with Leading Academic Medical Systems to Advance AI in Medical Imaging
- GE HealthCare Acquires Intelligent Ultrasound Group’s Clinical Artificial Intelligence Business
- Bayer and Rad AI Collaborate on Expanding Use of Cutting Edge AI Radiology Operational Solutions
- Polish Med-Tech Company BrainScan to Expand Extensively into Foreign Markets
Channels
Radiography
view channel
AI Boosts Breast Cancer Detection and Cuts Screening Workload
Breast cancer screening programs face rising demand and persistent workforce shortages, straining double-reading workflows and delaying care. Early detection is critical to reduce mortality and minimize... Read more
AI Tool Predicts Breast Cancer Risk Years Ahead Using Routine Mammograms
Breast cancer screening saves lives but still relies largely on uniform schedules despite wide differences in individual risk. This one-size-fits-all approach can miss cancers in higher-risk women while... Read more
MRI
view channel
MRI-Based AI Tool Supports Differentiation of Parkinsonian Syndromes
Clinicians often struggle to differentiate Parkinsonian syndromes at initial presentation, when symptom overlap can obscure disease trajectory and delay targeted care. Imaging markers derived from diffusion... Read more
MRI-Derived Biomarker Improves Risk Stratification in Glioblastoma
Glioblastoma is marked by rapid growth and diffuse infiltration that complicate prognosis and treatment planning. Clinicians need objective tools that capture both how these tumors expand and how they... Read more
Combined Imaging Approach Identifies Cause of Heart Attack without Coronary Blockage
Patients who present with myocardial infarction but show no obstructive coronary disease often leave without a definitive diagnosis. That uncertainty complicates in-hospital decision-making and post-discharge... Read more
Ultrasound
view channel
New Ultrasound AI Tool Supports Rapid Prenatal Assessment
Accurate gestational age estimation guides prenatal screening, detection of complications, and timely intervention. Access to ultrasound and trained sonographers is uneven, with nearly half of U.... Read more
New Consensus Standardizes Ultrasound-Based Fatty Liver Assessment
Metabolic dysfunction-associated steatotic liver disease (MASLD) is rising along with obesity and diabetes, making accurate, scalable measurement of hepatic fat a clinical priority. Biopsy is invasive... Read more
Nuclear Medicine
view channel
PET Tracer Enables Noninvasive Measurement of Beta Cell Mass
Type 1 diabetes is an autoimmune disease in which the immune system destroys insulin-producing pancreatic beta cells. Loss of these cells destabilizes glucose control and drives complications.... Read more
New Imaging Tool Sheds Light on Tumor Fat Metabolism
Rapidly growing tumors reprogram metabolism to meet high energy demands. While many cancers preferentially consume glucose, lipid utilization by malignant cells is difficult to measure in living subjects.... Read more
Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies
Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read more
General/Advanced Imaging
view channel
AI Tool Predicts Side Effects from Lung Cancer Treatment
Radiation therapy is a central treatment for lung cancer, but even carefully targeted radiation can affect surrounding healthy tissue. Patients may develop side effects such as lung inflammation, coughing,... Read more
AI Tool Offers Prognosis for Patients with Head and Neck Cancer
Oropharyngeal cancer is a form of head and neck cancer that can spread through lymph nodes, significantly affecting survival and treatment decisions. Current therapies often involve combinations of surgery,... Read more
Imaging IT
view channel
Breast Imaging Software Enhances Visualization and Tissue Characterization in Challenging Cases
Breast imaging can be particularly challenging in cases involving small breasts or implants, where image reconstruction and tissue characterization may be limited. Clinicians also need reproducible analysis... Read more
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
